Valley Wealth Managers’s AbbVie ABBV Stock Holding History

Valley Wealth Managers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.78M	Buy	26,564 +373	+1%	+$82.7K	0.37%	55
2025 Q4	$5.98M	Buy	26,191 +5	+0%	+$1.14K	0.38%	56
2025 Q3	$6.06M	Buy	26,186 +596	+2%	+$121K	0.4%	56
2025 Q2	$4.75M	Buy	25,590 +345	+1%	+$64.1K	0.34%	60
2025 Q1	$5.29M	Sell	25,245 -13	-0.1%	-$2.53K	0.4%	53
2024 Q4	$4.49M	Sell	25,258 -1,931	-7%	-$355K	0.34%	60
2024 Q3	$5.37M	Sell	27,189 -1,364	-5%	-$255K	0.4%	52
2024 Q2	$4.9M	Sell	28,553 -2,195	-7%	-$364K	0.39%	57
2024 Q1	$5.6M	Sell	30,748 -1,829	-6%	-$315K	0.42%	57
2023 Q4	$5.05M	Sell	32,577 -841	-3%	-$123K	0.39%	58
2023 Q3	$4.98M	Sell	33,418 -1,515	-4%	-$222K	0.42%	59
2023 Q2	$4.71M	Sell	34,933 -1,467	-4%	-$215K	0.42%	53
2023 Q1	$5.8M	Sell	36,400 -959	-3%	-$147K	0.53%	45
2022 Q4	$6.04M	Sell	37,359 -1,476	-4%	-$226K	0.56%	46
2022 Q3	$5.21M	Sell	38,835 -1,884	-5%	-$270K	0.52%	45
2022 Q2	$6.24M	Sell	40,719 -1,397	-3%	-$213K	0.58%	45
2022 Q1	$6.83M	Sell	42,116 -1,316	-3%	-$191K	0.57%	46
2021 Q4	$5.88M	Buy	43,432 +2,299	+6%	+$272K	0.47%	51
2021 Q3	$4.44M	Sell	41,133 -165	-0.4%	-$18.9K	0.39%	57
2021 Q2	$4.65M	Buy	41,298 +1,999	+5%	+$225K	0.39%	57
2021 Q1	$4.25M	Buy	39,299 +3,222	+9%	+$345K	0.38%	54
2020 Q4	$3.87M	Buy	36,077 +50	+0.1%	+$4.8K	0.38%	54
2020 Q3	$3.16M	Sell	36,027 -2,546	-7%	-$240K	0.35%	55
2020 Q2	$3.79M	Sell	38,573 -4,726	-11%	-$416K	0.42%	53
2020 Q1	$3.3M	Buy	43,299 +767	+2%	+$65.3K	0.43%	52
2019 Q4	$3.77M	Buy	42,532 +480	+1%	+$39.8K	0.38%	54
2019 Q3	$3.18M	Buy	42,052 +1,475	+4%	+$101K	0.34%	57
2019 Q2	$2.95M	Buy	40,577 +6,540	+19%	+$514K	0.31%	59
2019 Q1	$2.74M	Buy	34,037 +2,716	+9%	+$222K	0.3%	55
2018 Q4	$2.89M	Buy	31,321 +1,736	+6%	+$153K	0.38%	50
2018 Q3	$2.8M	Buy	29,585 +2,750	+10%	+$261K	0.33%	47
2018 Q2	$2.49M	Sell	26,835 -1,560	-5%	-$152K	0.3%	47
2018 Q1	$2.69M	Sell	28,395 -3,612	-11%	-$397K	0.33%	46
2017 Q4	$3.1M	Sell	32,007 -2,666	-8%	-$251K	0.37%	46
2017 Q3	$3.08M	Sell	34,673 -1,200	-3%	-$91.3K	0.39%	45
2017 Q2	$2.6M	Sell	35,873 -4,114	-10%	-$277K	0.35%	47
2017 Q1	$2.6M	Buy	39,987 +1,340	+3%	+$84.2K	0.35%	53
2016 Q4	$2.42M	Sell	38,647 -1,314	-3%	-$80.2K	0.35%	52
2016 Q3	$2.52M	Buy	39,961 +2,028	+5%	+$131K	0.37%	51
2016 Q2	$2.35M	Buy	37,933 +14,186	+60%	+$864K	0.36%	49
2016 Q1	$1.36M	Buy	23,747 +5,942	+33%	+$331K	0.23%	54
2015 Q4	$1.05M	Sell	17,805 -636	-3%	-$36.6K	0.19%	69
2015 Q3	$1M	Sell	18,441 -430	-2%	-$28K	0.18%	69
2015 Q2	$1.27M	Sell	18,871 -1,870	-9%	-$122K	0.22%	56
2015 Q1	$1.22M	Buy	20,741 +3,469	+20%	+$210K	0.21%	64
2014 Q4	$1.13M	Sell	17,272 -910	-5%	-$57.4K	0.2%	75
2014 Q3	$1.05M	Buy	18,182 +685	+4%	+$38K	0.2%	63
2014 Q2	$988K	Buy	17,497 +1,315	+8%	+$69K	0.19%	68
2014 Q1	$832K	Buy	16,182 +1,985	+14%	+$100K	0.17%	69
2013 Q4	$749K	Buy	14,197 +415	+3%	+$20.4K	0.15%	69
2013 Q3	$616K	Buy	13,782 +835	+6%	+$37K	0.13%	76
2013 Q2	$535K	Buy	+12,947	New	+$566K	0.12%	80

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Valley Wealth Managers's ABBV Position: Q1 2026 in Review

Valley Wealth Managers increased its AbbVie (ABBV) stake by 1.4% in Q1 2026, buying an estimated $82.7K and bringing the position to 26,564 shares worth $5.78M. The position accounts for 0.37% of the portfolio, ranked #55.

Valley Wealth Managers first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.83M in Q1 2022. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Valley Wealth Managers held 26,564 shares of AbbVie worth $5.78M as of Q1 2026.
Valley Wealth Managers bought 373 AbbVie shares in Q1 2026, an estimated $82.7K.
AbbVie made up 0.37% of Valley Wealth Managers's portfolio in Q1 2026, its #55 holding.
Valley Wealth Managers first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Valley Wealth Managers's AbbVie position peaked at $6.83M in Q1 2022.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Valley Wealth Managers's 13F filing for Q1 2026, filed 6 May 2026.